当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析 - 现金流量表

天坛生物

(600161)

  

流通市值:338.92亿  总市值:338.92亿
流通股本:19.77亿   总股本:19.77亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,075,023,127.551,736,558,359.18681,035,737.884,930,664,034.17
  收到的税费返还--7,800-
  收到其他与经营活动有关的现金83,623,172.2149,939,140.2821,960,381.56134,759,387.68
  经营活动现金流入小计3,158,646,299.761,786,497,499.46703,003,919.445,065,423,421.85
  购买商品、接受劳务支付的现金1,611,489,389.791,039,889,364.45503,200,062.742,222,626,557.33
  支付给职工以及为职工支付的现金669,693,580.99445,464,366.1238,229,201.951,135,421,616.41
  支付的各项税费586,001,241.1399,920,918.5218,444,163.72636,711,015.97
  支付其他与经营活动有关的现金174,567,059.81103,127,400.5344,770,204.23250,883,527.05
  经营活动现金流出小计3,041,751,271.691,988,402,049.581,004,643,632.644,245,642,716.76
  经营活动产生的现金流量净额116,895,028.07-201,904,550.12-301,639,713.2819,780,705.09
二、投资活动产生的现金流量:
  收回投资收到的现金---25,330,308
  取得投资收益收到的现金37,100,956.9637,100,956.96-21,500,000
  处置固定资产、无形资产和其他长期资产收回的现金净额138,228.379,930.752,446.7159,941.3
  收到的其他与投资活动有关的现金700,000,000700,000,000-1,000,000,000
  投资活动现金流入小计737,239,185.26737,180,887.6652,446.71,046,990,249.3
  购建固定资产、无形资产和其他长期资产支付的现金450,530,338.98325,460,519.56144,405,613.981,067,411,262.82
  取得子公司及其他营业单位支付的现金---963,780,936.99
  支付其他与投资活动有关的现金---874,914,240
  投资活动现金流出小计450,530,338.98325,460,519.56144,405,613.982,906,106,439.81
  投资活动产生的现金流量净额286,708,846.28411,720,368.1-144,353,167.28-1,859,116,190.51
三、筹资活动产生的现金流量:
  取得借款收到的现金252,966,301.4242,137,862.6334,737,094.71-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计252,966,301.4242,137,862.6334,737,094.71-
  分配股利、利润或偿付利息支付的现金706,402,398.36304,247,963.18-352,531,629.09
  其中:子公司支付给少数股东的股利、利润212,269,503.11107,143,523.23-105,360,198.39
  支付其他与筹资活动有关的现金18,726,597.110,930,606.632,068,648.4717,755,213.78
  筹资活动现金流出小计725,128,995.46315,178,569.812,068,648.47370,286,842.87
  筹资活动产生的现金流量净额-472,162,694.04-273,040,707.1832,668,446.24-370,286,842.87
四、汇率变动对现金及现金等价物的影响-9,499.67-2,279.48370.01-43,795.73
五、现金及现金等价物净增加额-68,568,319.36-63,227,168.68-413,324,064.23-1,409,666,124.02
  加:期初现金及现金等价物余额1,422,920,905.041,422,920,905.041,422,920,905.042,832,587,029.06
  期末现金及现金等价物余额1,354,352,585.681,359,693,736.361,009,596,840.811,422,920,905.04
补充资料:
  净利润-865,800,086.14-2,112,264,516.35
  资产减值准备-33,550,584.65-53,018,376.3
  固定资产和投资性房地产折旧-163,520,008.34-254,203,356.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-163,520,008.34-254,203,356.88
  无形资产摊销-37,830,420.75-58,342,884.7
  长期待摊费用摊销-16,831,522.75-31,302,677.14
  处置固定资产、无形资产和其他长期资产的损失--204,679.09--37,503.49
  固定资产报废损失-54,096.04-7,366,601.69
  财务费用-4,340,269.9-4,685,090.88
  投资损失--22,432,891.35--63,926,881.42
  递延所得税--10,792,107.38-2,303,381.97
  其中:递延所得税资产减少--4,514,683.67-5,649,907.66
    递延所得税负债增加--6,277,423.71--3,346,525.69
  存货的减少--40,628,592.84--579,842,533.14
  经营性应收项目的减少--1,340,914,398.19--473,117,126.79
  经营性应付项目的增加-78,271,390.42--613,096,821.24
  现金的期末余额-1,359,693,736.36-1,422,920,905.04
  减:现金的期初余额-1,422,920,905.04-2,832,587,029.06
  现金及现金等价物的净增加额--63,227,168.68--1,409,666,124.02
公告日期2025-10-252025-08-222025-04-262025-03-29
审计意见(境内)标准无保留意见
TOP↑